Latest News and Press Releases

CAMBRIDGE, U.K., May 14, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today noted recent press coverage on the identification of a risk gene for schizophrenia that has implications for its...

CAMBRIDGE, U.K., April 2, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) announced today that it had agreed with the administrators of Bioglan Pharma plc (LSE:BGP), the termination of their...

CAMBRIDGE, U.K., March 27, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced its results for the year ended Dec. 31, 2001 and an update on its restructuring plan. Key events...

CAMBRIDGE, U.K., Dec. 11, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) announced today that it had exchanged contracts to assign its head office lease at Compass House, Cambridge to De...

CAMBRIDGE, U.K., Nov. 29, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) announced today that it has signed an agreement to sell its chemical library of ion channel blockers to Scion...

CAMBRIDGE, United Kingdom, Nov. 14, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) announced today that it had signed an agreement worth $1.2 million for the supply of its proprietary ion...

CAMBRIDGE, UK, Nov. 12, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced an update on the progress it has made in the group restructuring that was first announced on October 1,...

CAMBRIDGE, UK, Oct. 30, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced that it is terminating the development and licence agreements it has with Bioglan Pharma Plc (LSE:BGP)...

CAMBRIDGE, UK, Oct. 1, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced its unaudited interim financial results for the six months ended June 30, 2001 and a planned...

CAMBRIDGE, UK, Sept. 16, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals Plc (LSE:CEN) today announced that it's drug delivery division, based in Scotland, has signed a strategic alliance with...